Skip to main content
PLOS One logoLink to PLOS One
. 2013 Oct 17;8(10):10.1371/annotation/f715f38e-7aee-4d2b-8bbf-da0411dc6ef3. doi: 10.1371/annotation/f715f38e-7aee-4d2b-8bbf-da0411dc6ef3

Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer

Zsuzsanna Varga, Peter Sinn, Florian Fritzsche, Arthur von Hochstetter, Aurelia Noske, Peter Schraml, Christoph Tausch, Andreas Trojan, Holger Moch
PMCID: PMC3806972

There was an error in the first sentence of the Funding Statement. The first sentence of the Funding Statement should read: "The funders of Sividion Diagnostics, Cologne, Germany conducted the Endopredict assay on all 34 tissue samples in a blinded way upon request of the authors."

Footnotes

Competing Interests: No competing interests declared.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES